Home/Filings/4/0001628280-24-006419
4//SEC Filing

Kanner Steven 4

Accession 0001628280-24-006419

CIK 0001619856other

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 5:15 PM ET

Size

7.3 KB

Accession

0001628280-24-006419

Insider Transaction Report

Form 4
Period: 2024-02-20
Kanner Steven
Chief Scientific Officer
Transactions
  • Award

    Option to purchase Common Stock

    2024-02-20+153,000153,000 total
    Exercise: $6.81Exp: 2034-02-19Common Stock (153,000 underlying)
  • Award

    Common Stock

    2024-02-20+33,000387,037 total
Footnotes (2)
  • [F1]This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on February 20, 2025, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date.
  • [F2]25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2025, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.

Issuer

Caribou Biosciences, Inc.

CIK 0001619856

Entity typeother

Related Parties

1
  • filerCIK 0001871131

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 5:15 PM ET
Size
7.3 KB